U.S. Physical Therapy (USPH) to Release Quarterly Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH - Get Free Report) is expected to release its earnings data before the market opens on Wednesday, February 26th. Analysts expect U.S. Physical Therapy to post earnings of $0.69 per share and revenue of $173.10 million for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.

U.S. Physical Therapy Stock Down 2.5 %

Shares of U.S. Physical Therapy stock traded down $2.16 on Friday, hitting $83.91. The company had a trading volume of 141,272 shares, compared to its average volume of 86,652. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of 89.26, a P/E/G ratio of 3.62 and a beta of 1.48. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The stock has a 50 day moving average of $89.21 and a 200-day moving average of $87.82. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares of the company's stock, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on USPH. Barrington Research reissued an "outperform" rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 3rd. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an "outperform" rating and a $113.00 price target for the company. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $114.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.